HuGE Literature Finder
Records 1-30
|
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
BMC cancer 2021 Jun 21 (1): 674. Nakajima Hiromichi, Kotani Daisuke, Bando Hideaki, Kato Takeshi, Oki Eiji, Shinozaki Eiji, Sunakawa Yu, Yamazaki Kentaro, Yuki Satoshi, Nakamura Yoshiaki, Yamanaka Takeharu, Yoshino Takayuki, Ohta Takashi, Taniguchi Hiroya, Kagawa Yoshino |
|
Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy.
Anticancer research 2021 Feb 41 (2): 829-834. Nakamura Masaki, Kageyama Shun-Ichiro, Seki Masahide, Suzuki Ayako, Okumura Masayuki, Hojo Hidehiro, Motegi Atsushi, Akimoto Tets |
|
Results of in vitro test-KRAStissue reagent kit test to determine indications for target therapy of patients diagnosed with colorectal cancer.
Klinicheskaia laboratornaia diagnostika 2020 Dec 65 (12): 793-800. Toropovskiy A N, Pavlova Olga Nikolaevna, Viktorov D A, Nikitin A G, Maslyakov V |
|
Early-onset colorectal cancer: A distinct entity with unique genetic features.
Oncology letters 2020 Oct 20 (4): 33. Jiang Dan, Shu Chang, Lei Chuanfen, Wan Ying, Sun Linyo |
|
Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.
Cancers 2020 Jul 12 (7): . Ottaiano Alessandro, Normanno Nicola, Facchini Sergio, Cassata Antonino, Nappi Anna, Romano Carmela, Silvestro Lucrezia, De Stefano Alfonso, Rachiglio Anna Maria, Roma Cristin, Maiello Monica R, Scala Stefania, Delrio Paolo, Tatangelo Fabiana, Di Mauro Annabella, Botti Gerardo, Avallone Antonio, Nasti Gugliel |
|
RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
Pathology, research and practice 2020 Feb 152898. Ta To Van, Nguyen Quang Ngoc, Chu Ha Hoang, Truong Van-Long, Vuong Linh Di |
|
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
Cancer medicine 2019 Nov . Ye Zu-Lu, Qiu Miao-Zhen, Tang Tao, Wang Fang, Zhou Yi-Xin, Lei Meng-Jie, Guan Wen-Long, He Cai-Y |
|
Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine.
The EPMA journal 2019 Sep 10 (3): 307-316. Mihajlovic Marija, Ninic Ana, Sopic Miron, Miljkovic Milica, Stefanovic Aleksandra, Vekic Jelena, Spasojevic-Kalimanovska Vesna, Zeljkovic Dejan, Trifunovic Bratislav, Stjepanovic Zeljka, Zeljkovic Aleksand |
|
Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.
Molecular diagnosis & therapy 2019 Jul . Chen Chi-Long, Chen Chi-Kuan, Ho Chung-Liang, Chi Wei-Ming, Yeh Chien-Hsuan, Hu Shian-Pin, Friebe Peter, Palmer Stuart, Huang Chin-Shi |
|
High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer.
Asian Pacific journal of cancer prevention : APJCP 2019 08 20 (8): 2319-2326. Korphaisarn Krittiya, Pongpaibul Ananya, Roothumnong Ekkapong, Pongsuktavorn Khontawan, Thamlikitkul Lucksamon, Anekpuritanang Tauangtham, Poungvarin Naravat, Thongnoppakhun Wanna, Pithukpakorn Man |
|
rs187960998 polymorphism in miR-211 prevents development of human colon cancer by deregulation of 3'UTR in CHD5.
OncoTargets and therapy 2019 12 405-412. Zhu Limei, Wang Ran, Zhang Li, Zuo Chunlei, Zhang Rui, Zhao Shaol |
|
Impact of the Ser326Cys polymorphism of the OGG1 gene on the level of oxidative DNA damage in patients with colorectal cancer.
Polski przeglad chirurgiczny 2018 Apr 90 (2): 13-15. Kabzinski Jacek, Walczak Anna, Dziki Adam, Mik Micha?, Majsterek Ireneu |
|
Real-time PCR-based method for the rapid detection of extended RAS mutations using bridged nucleic acids in colorectal cancer.
Clinica chimica acta; international journal of clinical chemistry 2017 Oct . Iida Takao, Mizuno Yukie, Kaizaki Yasuha |
|
Investigation of methylenetetrahydrofolate reductase tagging polymorphisms with colorectal cancer in Chinese Han population.
Oncotarget 2017 Sep 8 (38): 63518-63527. Zhang Sheng, Chen Shuchen, Chen Yu, Kang Mingqiang, Liu Chao, Qiu Hao, Wang Yafeng, Tang Weife |
|
Investigation of methylenetetrahydrofolate reductase tagging polymorphisms with colorectal cancer in Chinese Han population.
Oncotarget 2017 Jun . Zhang Sheng, Chen Shuchen, Chen Yu, Kang Mingqiang, Liu Chao, Qiu Hao, Wang Yafeng, Tang Weife |
|
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
BMC cancer 2017 01 17 (1): 38. Nakayama Izuma, Shinozaki Eiji, Matsushima Tomohiro, Wakatsuki Takeru, Ogura Mariko, Ichimura Takashi, Ozaka Masato, Takahari Daisuke, Suenaga Mitsukuni, Chin Keisho, Mizunuma Nobuyuki, Yamaguchi Kens |
|
Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Molecular cancer 2016 Oct 15 (1): 63. Kovaleva Valentina, Geissler Anna-Lena, Lutz Lisa, Fritsch Ralph, Makowiec Frank, Wiesemann Sebastian, Hopt Ulrich T, Passlick Bernward, Werner Martin, Lassmann Sil |
|
Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing.
Medical oncology (Northwood, London, England) 2016 Oct 33 (10): 106. Jauhri Mayank, Bhatnagar Akanksha, Gupta Satish, Shokeen Yogender, Minhas Sachin, Aggarwal Shy |
|
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology.
Oncotarget 2016 Mar . Ibarrola-Villava Maider, Fleitas Tania, Llorca-Cardeñosa Marta J, Mongort Cristina, Alonso Elisa, Navarro Samuel, Burgues Octavio, Vivancos Ana, Cejalvo Juan Miguel, Perez-Fidalgo José Alejandro, Roselló Susana, Ribas Gloria, Cervantes Andr |
|
Novel Approach for Clinical Validation of the cobas KRAS Mutation Test in Advanced Colorectal Cancer.
Molecular diagnosis & therapy 2016 Mar . Sharma Abha, Zhang Guili, Aslam Shagufta, Yu Karen, Chee Melody, Palma John |
|
Diagnostic yield of targeted next generation sequencing in various cancer types: An information-theoretic approach.
Cancer genetics 2015 Sep 208 (9): 441-7. Hagemann Ian S, O'Neill Patrick K, Erill Ivan, Pfeifer John |
|
KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
Experimental and molecular pathology 2015 Jun 98 (3): 563-7. de Macêdo Mariana Petaccia, de Melo Fernanda Machado, Lisboa Bianca Cristina Garcia, Andrade Louise D Brot, de Souza Begnami Maria Dirlei Ferreira, Junior Samuel Aguiar, Ribeiro Heber Salvador de Castro, Soares Fernando Augusto, Carraro Dirce Maria, da Cunha Isabela Werne |
|
Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Journal of gastrointestinal cancer 2015 Jun 46 (2): 118-25. Zeinalian Mehrdad, Emami Mohammad Hassan, Salehi Rasoul, Naimi Azar, Kazemi Mohammad, Hashemzadeh-Chaleshtori Morte |
|
Identification of novel mutations by exome sequencing in African American colorectal cancer patients.
Cancer 2015 Jan 121 (1): 34-42. Ashktorab Hassan, Daremipouran Mohammad, Devaney Joe, Varma Sudhir, Rahi Hamed, Lee Edward, Shokrani Babak, Schwartz Russell, Nickerson Michael L, Brim Hass |
|
Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer.
SpringerPlus 2015 4 7. Sakai Kazuko, Yoneshige Azusa, Ito Akihiko, Ueda Yoji, Kondo Satoshi, Nobumasa Hitoshi, Fujita Yoshihiko, Togashi Yosuke, Terashima Masato, De Velasco Marco A, Tomida Shuta, Nishio Kazu |
|
Investigating of microsatellites instability in patients with hereditary non-polyposis colorectal cancer in Isfahan.
Advanced biomedical research 2014 3 145. Homayouni Vida, Salehi Mansour, Kazemi Mohamm |
|
Influence of KRAS and BRAF mutational status and rash on disease-free survival (DFS) in patients with resected stage III colon cancer receiving cetuximab (Cmab): Results from NCCTG N0147.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 3607. Alberts S R, Thibodeau S N, Sargent D J, Mahoney M R, Sinicrope F, Shields A F, Chan E, Goldberg R M, Gill S, Kahlenberg M S, Quesenberry J T, Smyrk T C, Grothey A, Nair S |
|
Molecular alterations in brain metastases from colorectal tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e14082. Denis M G, Loussouarn D, Theoleyre S, Martin S, Heymann M, Aillet G, Rioux-Leclercq N, Magois C, Auger J J, Vansteene D, Bennouna |
|
Molecular analysis of KRAS polymorphism mutation using a high-resolution melting system in a large mCRC patients sample in Mexico.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e14132. Astudillo H, Ruiz-Garcia E B, Vazquez V M, Bastarrachea J, Romero-Garcia P, Silva A J, Ruiz-Calzada H, Lopez-Yañez A, Cortes Esteban |
|
MicroRNA profile and KRAS status in metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Feb 29 (4_suppl): 453. Valladares-Ayerbes M, Blanco M, Reboredo M, Lorenzo-Patiño M J, Arnal F, Haz Conde M, Medina Villaamil V, Santamarina Caínzos I, Antón Aparicio L M, Calvo Martinez |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jun 09, 2021
- Content source: